LOS ANGELES — Amanda Bynes says she has lost 28 pounds since starting Ozempic, sharing that her weight has dropped from 180 to 152 in a Dec. 22 Instagram Story update. The former child star said a candid paparazzi photo that once would have made her uncomfortable is now “really inspiring,” as she continues working toward a longer-term goal, Dec. 27, 2025.
Amanda Bynes Ozempic update: an “inspiring” milestone
In the Story, Bynes wrote that she “usually” doesn’t like paparazzi pictures, but said the latest snapshot helped her see progress in a way she hadn’t before. Celebrity outlets including People and E! News reported that she posted the message over a photo of herself taken earlier this month while running errands.
For many public figures, weight-loss talk can quickly turn into spectacle. In this case, the Amanda Bynes Ozempic update reads more like a personal note to herself: a moment of motivation, not a branded announcement. She did not share details such as dosage, a prescribing physician or a timeline for her next check-in, but she emphasized the mental shift, writing that the photo was “really inspiring.”
Bynes has also previously discussed how changes in mental health affected her habits, telling followers in earlier posts that depression contributed to weight gain and that she has worked to recommit to exercise and “eating clean.” The new update leans into that same theme — less about a dramatic reveal and more about staying consistent when she doesn’t feel like it.
The Amanda Bynes Ozempic journey began publicly in June
The Amanda Bynes Ozempic journey has unfolded in small, self-posted snapshots rather than in sit-down interviews. In June, she said in an Instagram Story video that she was starting the medication and hoped to reach about 130 pounds — a goal she tied to feeling more confident in candid photos, according to Entertainment Weekly.
Those updates arrive against a longer personal timeline that Bynes has largely navigated outside the spotlight. A judge ended her nearly nine-year conservatorship in March 2022, the Los Angeles Times reported. In March 2023, she was placed on a mental health hold after calling 911 for help, according to ABC News.
What to know about Ozempic and semaglutide
Ozempic is the brand name for semaglutide, a prescription drug approved by the U.S. Food and Drug Administration to improve blood sugar control in adults with type 2 diabetes (and for certain cardiovascular risk reduction), according to the Ozempic prescribing information. Wegovy contains the same active ingredient, semaglutide, but is FDA-approved for chronic weight management in certain adults with obesity or overweight and at least one weight-related condition, according to the Wegovy prescribing information.
Both medications include boxed warnings and list side effects and risks that should be reviewed with a clinician before starting or changing treatment. The FDA has also cautioned consumers about dosing errors and adverse events tied to some compounded versions of semaglutide, urging medical guidance in an agency safety alert.
Whether or not fans agree with her reasons, the Amanda Bynes Ozempic conversation underscores a familiar reality of celebrity life: unwanted photos can shape self-image, and self-image can influence health decisions. Bynes’ latest post offers a rare, personal check-in from a star who has repeatedly stepped back from public attention — and a reminder that medication and body-image discussions are most helpful when handled with context and care.
